ARTICLE | Company News
Coley, Sanofi-Aventis S.A. deal
September 20, 2004 7:00 AM UTC
Coley received a $5 million milestone from SAN, triggered by SAN beginning a Phase I trial of the first of Coley's CpG TLR therapeutics to treat allergic respiratory disease. Under a 2001 deal, Coley ...